Cipher Oncology Profile
Key Indicators
- Authorised Capital ₹ 4.25 Cr
as on 04-07-2024
- Paid Up Capital ₹ 1.93 Cr
as on 04-07-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 56.79%
(FY 2023)
- Profit -39.49%
(FY 2023)
- Ebitda -39.60%
(FY 2023)
- Net Worth 119.31%
(FY 2023)
- Total Assets 76.88%
(FY 2023)
About Cipher Oncology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.25 Cr and a paid-up capital of Rs 1.93 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sonali Srungaram and Sasi Sunkara serve as directors at the Company.
- CIN/LLPIN
U85100TG2019PTC132422
- Company No.
132422
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2019
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cipher Oncology?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sonali Srungaram  | Managing Director | 30-Apr-2019 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sasi Sunkara | Director | 30-Apr-2019 | Current |
Financial Performance of Cipher Oncology.
Cipher Oncology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 56.79% increase. The company also saw a substantial fall in profitability, with a 39.49% decrease in profit. The company's net worth Soared by an impressive increase of 119.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cipher Oncology?
In 2023, Cipher Oncology had a promoter holding of 80.47% and a public holding of 19.53%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cipher Healthcare Private LimitedActive 12 years 2 monthsSonali Srungaram and Sasi Sunkara are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cipher Oncology?
Cipher Oncology has a workforce of 95 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cipher Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cipher Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
